An example of a situation that human could suffer from his own innovations in the field of medicine is the case involving a drug called TGN1412 in England, where 6 lives were threatened in March 2006. This incident highlighted ethical issues in clinical study design and safety monitoring.
The main stakeholders in the case given include the StarAlpha Medicines, with its research and Development Department directly involved, and Country X with the direct participation of its citizen specifically the poor women who will be the potential subjects of the clinical trials to be carried out. StarAlpha Medicines could benefit a lot if the CEO's suggestion will materialize. The said pharmaceutical company, as the future main distributor of the drugs being developed, will be able to achieve skyrocketing sales. Also, if the strict procedures in clinical trials being observed in Europe will not be followed and taken for granted, instead it will be carried out in country X where a more favorable conditions for clinical trial are offered, it will be an effective mean of cost-cutting on the part of the pharmaceutical company - less expense but big revenues.
Country X on the other hand, will reap both the positive effects and the possible negative o ...